APA (7th ed.) Citation

Middeke, J. M., Teipel, R., Röllig, C., Stasik, S., Zebisch, A., Sill, H., . . . Burchert, A. (2021). Decitabine treatment in 311 patients with acute myeloid leukemia: Outcome and impact of TP53 mutations – a registry based analysis. Leukemia & Lymphoma, 62(6), 1432. https://doi.org/10.1080/10428194.2020.1864354

Chicago Style (17th ed.) Citation

Middeke, Jan M., et al. "Decitabine Treatment in 311 Patients with Acute Myeloid Leukemia: Outcome and Impact of TP53 Mutations – a Registry Based Analysis." Leukemia & Lymphoma 62, no. 6 (2021): 1432. https://doi.org/10.1080/10428194.2020.1864354.

MLA (9th ed.) Citation

Middeke, Jan M., et al. "Decitabine Treatment in 311 Patients with Acute Myeloid Leukemia: Outcome and Impact of TP53 Mutations – a Registry Based Analysis." Leukemia & Lymphoma, vol. 62, no. 6, 2021, p. 1432, https://doi.org/10.1080/10428194.2020.1864354.